Insider Transactions in Q2 2023 at Health Sciences Acquisitions Corp 2 (HSAQ)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2023
|
Eric A Md Rose Director |
SELL
Payment of exercise price or tax liability
|
Direct |
157
-6.75%
|
$2,512
$16.04 P/Share
|
|
May 17
2023
|
Eric A Md Rose Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,325
+50.0%
|
$2,325
$1.08 P/Share
|
|
May 10
2023
|
Eric S Fain Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
2,906
+8.89%
|
$2,906
$1.08 P/Share
|
|
Apr 13
2023
|
Rtw Investments, LP > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
502,133
+8.2%
|
-
|
|
Apr 12
2023
|
Geoffrey Wade Smith Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
327,617
+15.15%
|
-
|
|
Apr 12
2023
|
Geoffrey Wade Smith Director |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+15.15%
|
-
|
|
Apr 12
2023
|
Yuval Mika Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,852
+15.15%
|
-
|
|
Apr 12
2023
|
Jason Aryeh Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,246
+15.15%
|
-
|
|
Apr 12
2023
|
Michael Kaswan Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
29,029
+15.15%
|
-
|
|
Apr 12
2023
|
Connealy Pamela Yanchik Director |
BUY
Exercise of conversion of derivative security
|
Direct |
758
+15.15%
|
-
|
|
Apr 12
2023
|
Eric S Fain Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,796
+15.15%
|
-
|
|
Apr 12
2023
|
Darren Sherman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
14,959
+15.15%
|
-
|
|
Apr 12
2023
|
David P Hochman Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
11,843
+15.15%
|
-
|
|
Apr 12
2023
|
David P Hochman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
29,551
+15.15%
|
-
|